| 2169919-21-3 Basic information More.. |
Product Name: | SNDX-5613 | Synonyms: | SNDX-5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-;SNDX-5613 SNDX5613;Revumenib | CAS: | 2169919-21-3 | MF: | C32H47FN6O4S | MW: | 630.82 | EINECS: | | Mol File: | 2169919-21-3.mol | |
SNDX-5613 manufacturers
- SNDX-5613
-
- US $1.00 / box
- 2022-11-21
- CAS:2169919-21-3
- Min. Order: 1box
- Purity: 98%
- Supply Ability: 1
|
2169919-21-3
Recommend Suppliers |
|